marinedrugs Marine Drugs Mar. Drugs Marine Drugs 1660-3397 MDPI 10.3390/md10071445 marinedrugs-10-01445 Article Formamido-Diterpenes from the South China Sea Sponge Acanthella cavernosa Xu Ying 1 2 Lang Jun-Hui 1 Jiao Wei-Hua 1 Wang Ru-Ping 1 2 Peng Ying 2 Song Shao-Jiang 2 * Zhang Bao-Hua 3 * Lin Hou-Wen 1 * Laboratory of Marine Drugs, Department of Pharmacy, Changzheng Hospital, Second Military Medical University, Shanghai 200003, China; Email: xy30490@126.com (Y.X.); zhenshanmei.hui@163.com (J.-H.L.); weihuajiao@hotmail.com (W.-H.J.); wangruping_sy@yahoo.com.cn (R.-P.W.) College of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, Shenyang 110016, China; Email: yingpeng1999@yahoo.com.cn Eastern Hepatobiliary Surgical Hospital, Second Military Medical University, Shanghai 200438, China Authors to whom correspondence should be addressed; Email: songsj99@yahoo.com.cn (S.-J.S.); zhbh_1@tom.com (B.-H.Z.); franklin67@126.com (H.-W.L.); Tel./Fax: +86-24-23986510 (S.-J.S.); +86-21-81875272 (B.-H.Z.); +86-21-65585154 (H.-W.L.). 02 07 2012 07 2012 10 7 1445 1458 15 05 2012 01 06 2012 16 06 2012 © 2012 by the authors; licensee MDPI, Basel, Switzerland. 2012

This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).

Seven new formamido-diterpenes, cavernenes A–D (1–4), kalihinenes E and F (5–6), and kalihipyran C (7), together with five known compounds (8–12), were isolated from the South China Sea sponge Acanthella cavernosa. Structures were established using IR, HRESIMS, 1D and 2D NMR, and single X-ray diffraction techniques. The isolated compounds were assessed for their cytotoxicity against a small panel of human cancer cell lines (HCT-116, A549, HeLa, QGY-7701, and MDA-MB-231) with IC50 values in the range of 6–18 μM. In addition, compound 9 showed weak antifungal activity against Trichophyton rubrum and Microsporum gypseum with MIC values of 8 and 32 μg/mL, respectively, compound 10 displayed weak antifungal activity against fungi Candida albicans, Cryptococcus neoformans, T. rubrum, and M. gypseum with MIC values of 8, 8, 4, and 8 μg/mL, respectively.

 Acanthella cavernosa formamido-diterpenes cytotoxicity antifungal activity 1. Introduction

Marine sponges of the genus Acanthella have proven to be a rich source of new diterpenes and sesquiterpenes containing nitrogenous functional groups, including isonitrile (–NC), isothiocyanate (–NCS), isocyanate (–NCO), and formamide (–NHCHO) functionalities, which show various promising biological activities [1,2,3,4,5,6,7]. Diterpenes isolated from this genus have demonstrated cytotoxic [8], anthelmintic [9,10], antimalarial [11], antimicrobial [12], antifungal [1,13,14], and antifouling activities [15,16,17]. In general, these diterpenes can be divided into two types, defined by having a trans- or cis-decalin moiety. The diterpene precursor has been supposed to be geranylgeraniol, which cyclizes to form a cis- or trans-biflorane skeleton [6]. In our previous study, we had reported the isolation of eight new diterpenes, kalihinols M–T, together with seven known compounds from the CH2Cl2 extract of the sponge A. cavernosa [18]. As part of our interest on bioactive secondary metabolites from the marine sponges of the genus Acanthella, a petroleum ether extract of A.cavernosa was investigated and found to be cytotoxic. Further bioassay-guided fractionation of the extract led to the isolation of 12 formamido-diterpenes (1–12), including seven new ones (1–7) (Figure 1). Details of the isolation, structure elucidation, cytotoxic and antifungal activities of these compounds are described herein.

Structures 1–12 isolated from Acanthella cavernosa.

 2. Results and Discussion

The sponge A. cavernosa was exhaustively extracted with acetone, and after being subjected to extensive column chromatography on silica gel, Sephadex LH-20, ODS, and semipreparative HPLC, compounds 1–12 were obtained. The known compounds, kalihipyran A (8) [16], 15-formamido-kalihinene (9) [6], 10-formamido-kalihinene (10) [6], and kalihinenes X (11) and Y (12) [15], were identified by comparison of their spectroscopic data with literature values.

In the 1H and 13C NMR spectra of compounds 1–7, most signals were doubled in the ratio of ~1.8:1, 2.2:1, 1.1:1, 1.4:1, 2.1:1, 1.9:1, and 1.1:1, respectively. This suggested that 1-7 existed as equilibrium mixtures derived from the s-trans and s-cis forms of formamide groups, as in the cases of 8–12 [6,15,16], which was supported by IR absorptions (1, 1670; 2, 1681; 3, 1668; 4, 1681; 5, 1682; 6, 1686; and 7, 1668 cm−1) [16]. The assignments of the formamide groups (NH and CHO) in 1–7 for s-trans isomers and s-cis isomers were confirmed by HSQC and COSY data (Table 1 and Table 2).

marinedrugs-10-01445-t001_Table 1

1H NMR data of compounds 1–7 (CDCl3, J in Hz).

Position 1 a, c 2 b, c 3 a, c 4 a, c 5 b, c 6 a, c 7 a, d
1 1.24 m 1.26 m e 1.65 m e 1.30 m e 1.30 m 1.96 m 2.40 m
2a 1.84 m 1.34 m 1.73 m 1.85 m 1.84 m e 1.87 m 1.48 m e
2b 1.30 m 1.26 m e 1.65 m e 1.30 m e 1.28 m 1.48 m 1.48 m e
3a 1.99 m e 1.97 m e 1.99 m e 2.00 m e 1.93 m e 2.01 m 2.00 m e
3b 1.99 m e 1.97 m e 1.99 m e 2.00 m e 1.93 m e 1.89 m 2.00 m e
5 5.24 br s 5.47 br s 5.49 br d (4.0) 5.69 br s 6.37 br s 5.70 br s 5.39 br s
6 2.05 m 1.91 m 2.15 m 2.18 m 2.11 m 2.20 m 2.20 m
7 1.73 m 1.14 m 1.43 m e 1.17 m 1.58 m 1.62 m 1.78 m e
8a 1.66 m 1.53 m 1.43 m e 1.43 m 1.10 m 1.74 m 1.55 m e
8b 1.50 m 1.26 m 1.26 m 1.57 m 1.75 m 1.94 m 1.55m e
9a 1.89 m 1.88 m 1.65 m e 1.90 dt (9.5, 3.5) 1.89 m 5.32 br s 1.55 m e
9b 1.62 m e 1.56 m 1.55 m e 1.60 m 1.62 m 1.55 m e
11 1.97 m e 1.75 m
12a 1.99 m e 1.26m e 1.24 m e 2.62 t (6.5) 1.28 m e 1.78 m 5.61 m e
12b 1.99 m e 1.26 m e 1.24 m e 1.28 m e 1.63 m
13a 2.13 m 1.97 m e 1.99 m e 2.23 m e 2.27 m 1.83 m 2.18 m
13b 1.99 m e 1.97 m e 1.90 m 2.23 m e 1.97 m 1.56 m 2.13 m
14 5.13 t (5.5) 5.11 t (6.0) 5.08 br s 5.19 t (6.5) 3.93 m 3.75 t (7.0) 3.89 br s
16 1.69 s 1.69 s 1.67 s 1.72 s 1.39 s 1.31 s 4.88 s
5.01 s
17 1.62 s e 1.60 s 1.59 s 1.62 s 1.31 s 1.20 s 1.78 s e
18 4.89 br s 0.78 d (6.9) 0.83 d (6.5) 1.26 s 1.22 s e 1.18 s 4.16 br s e
4.80 br s 4.16 br s e
19 1.62 s e 1.67 s 1.65 s e 1.68 s 1.65 s 1.68 s 1.62 s
20 1.28 s 1.22 s 1.43 s e 1.27 s 1.22 s e 1.68 s 1.55 s e
NH 5.89 d (12.5) 6.10 d (11.8) 5.62 d (12.0) 5.92 d (12.0) 5.66 d (12.5) 5.86 m 5.61 m e
CHO 8.30 d (12.0) 8.27 d (12.3) 8.24 d (12.5) 8.29 d (12.5) 8.28 d (12.5) 8.19 d (12.5) 8.08 d (2.0)

a Measured at 500 MHz; b Measured at 400 MHz; c Data for major s-trans isomer; d Data for major s-cis isomer; e Overlapped.

Cavernene A (1) was isolated as a colorless oil. A molecular formula of C21H33ON was established by the [M + Na]+ ion peak at m/z 338.2461 in the HRESIMS and supported by NMR data (Table 1 and Table 2), indicating six degrees of unsaturation. The 1H NMR spectrum showed the presence of four tertiary methyl [δH 1.28 (3H, s), 1.62 (6H, s), and 1.69 (3H, s)] and four olefinic proton signals resonated at δH 4.80 (1H, br s), 4.89 (1H, br s), 5.13 (1H, t, J = 5.5 Hz), and 5.24 (1H, br s). The 13C NMR and DEPT spectra of 1 displayed 21 carbon resonances for four methyls, seven methylenes (one olefinic), six methines (two olefinic and one formamido), and four quaternary carbons (three olefinic). The above moieties accounted for four of six degrees of unsaturation, indicating a bicyclic structure for 1. The COSY correlations of H-9/H-8/H-7/H-6/H-1/H-2/H-3/H-5/H-19, together with the HMBC correlations of H3-19/C-3, C-4, and C-5, H3-20/C-1, C-9, and C-10, H-5/C-1, C-3, C-6, and C-7, and CHO/C-10 indicated the presence of a decalin moiety (Figure 2). The HMBC correlations from the geminal methyls (H3-16 and H3-17) to C-14 and C-15, from terminal olefinic protons (H2-18) to C-7, C-11, and C-12, and from H-13 to C-11, C-12, C-14, and C-15 and COSY correlation between H-13 and H-14 revealed the presence of an isoprenoid unit homolog in 1 and connectivity of the two moieties between C-12 and C-7 through the quaternary carbon C-11.

marinedrugs-10-01445-t002_Table 2

13C NMR data (CDCl3, δ in ppm) of compounds 1–7.

C 1 a 2 b 3 a 4 a 5 b 6 a 7 a
s- trans s- cis s- trans s- cis s- trans s- cis s- trans s- cis s- trans s- cis s- trans s- cis s- cis s- trans
1 48.8 45.3 49.0 45.7 45.6 41.1 48.4 45.0 48.8 46.1 40.1 40.1 40.9 45.4
2 22.8 23.1 22.9 23.4 19.1 19.5 22.7 23.1 23.3 23.7 24.6 24.7 18.8 19.1
3 30.96 31.04 30.8 30.9 31.3 31.4 30.8 30.9 30.5 30.6 30.5 30.6 31.1 31.2
4 134.4 134.1 134.9 134.6 134.3 134.2 134.8 134.3 132.4 131.9 131.1 130.8 134.5 134.4
5 123.3 123.8 121.8 122.3 124.3 124.0 122.3 122.7 125.7 126.2 127.1 127.3 123.9 124.2
6 39.5 39.4 38.4 38.2 35.2 34.8 38.6 38.4 39.5 39.2 36.5 36.5 37.0 36.5
7 50.3 50.3 44.6 44.4 42.3 42.0 45.2 45.2 51.2 50.4 44.9 45.2 43.3 43.6
8 29.7 29.9 20.9 20.9 20.1 19.9 25.7 25.8 24.5 24.7 29.48 29.51 28.4 28.4
9 42.0 37.6 41.8 37.4 33.0 33.7 41.7 37.3 42.1 37.8 120.2 120.5 33.5 32.8
10 55.5 57.2 55.6 57.3 55.5 57.1 55.3 56.8 55.4 56.9 136.9 136.8 56.8 55.4
11 151.3 151.9 30.8 30.8 31.3 31.1 62.33 62.7 76.9 77.2 86.4 86.3 139.4 139.0
12 34.2 34.2 35.65 35.69 35.7 35.8 62.27 62.33 31.0 31.7 37.2 37.1 118.6 118.9
13 26.3 26.3 26.2 26.2 26.2 26.3 27.0 27.0 25.9 26.1 25.6 25.8 29.6 29.6
14 124.2 124.3 124.6 124.8 124.7 124.9 119.3 119.5 64.2 64.5 84.2 84.5 77.2 76.8
15 131.7 131.6 131.3 131.1 131.2 131.1 134.2 134.1 74.2 74.4 54.5 55.9 145.4 145.3
16 25.7 25.7 25.7 25.7 25.7 25.7 25.7 25.7 29.7 29.7 27.4 25.1 110.5 110.6
17 17.8 17.8 17.7 17.7 17.7 17.7 18.0 18.0 28.9 28.4 23.8 21.7 18.9 18.9
18 110.0 109.6 13.3 13.3 13.3 13.3 18.5 18.5 21.9 21.2 20.3 21.1 67.63 67.58
19 23.3 23.4 23.6 23.7 23.5 23.4 23.55 23.60 23.8 23.8 23.92 23.87 23.3 23.4
20 19.0 18.9 18.8 18.7 27.2 23.7 18.9 18.7 19.0 18.5 21.53 21.47 23.6 29.7
21 162.8 160.4 163.1 160.5 162.8 160.0 162.8 160.4 162.7 160.4 163.1 160.9 160.1 162.8

a Measured at 125 MHz; b Measured at 100 MHz.

The relative configuration of 1 was established on the basis of NOESY data (Figure 2). The NOESY correlations of H-1/H-7 and NH/H-1 indicated that these protons were on the same face of the decalin ring and arbitrarily assigned β-orientations. The α-orientation of H-6 was determined by the NOESY correlation between H3-20 and H-6. In addition, the carbon resonances at δC 48.8 (C-1), 39.5 (C-6), 42.0 (C-9), and 19.0 (C-20) in 1 further confirmed the trans fusion of the decalin ring [6,8,15]. Cavernene A (1) can be envisaged as a decomposable intermediate product of isocyanobifloradiene epoxides in the plausible biogenetic pathway of kalihiprans [3,19].

COSY (▬), key HMBC (→), and key NOESY correlations of 1.

Cavernene B (2) was obtained as a colorless oil. Its molecular formula of C21H35ON was deduced from the HRESIMS (m/z 340.2617 [M + Na]+) combined with its NMR data (Table 1 and Table 2), indicating five degrees of unsaturation. The 1H and 13C NMR spectra of 1 and 2 were comparable except for a marked difference in the isoprenoid unit. Signals for a C-11–C-18 double bond were absent in 2 and replaced by saturated carbons resonated at δC 30.8 and 13.3, respectively. The HMBC correlations of H3-18/C-7, C-11, and C-12 and the COSY correlations of H3-18/H-11/H-12 and H-11/H-7 supported the assignment of convernene B as 2. The relative configuration of the decalin ring in 2 was the same as in 1, with the observation of the NOESY correlations of NH/H-1, H3-20/H-6, NH/H-9b, H-7/H-9b, and H3-20/H-9a (Supporting Information). The relative configuration at C-11, however, could not be conclusively determined due to conformational flexibility between C-7 and C-11.

Cavernene C (3), obtained as white needles, showed the same molecular formula of C21H35ON as 2 determined by pseudomolecular [M + Na]+ ion peak at m/z 340.2614 in HRESIMS. Its carbon skeleton was readily assignable as the same as 2 by HSQC, HMBC, and COSY spectra. In particular, the carbon resonances of the isoprenoid unit in 3 were almost superimposable on those of 2 (Table 2), suggesting the same stereostructure of the isoprenoid unit for both 2 and 3. On the other hand, differences were observed for the signals of the decalin ring . Specifically, the carbon resonances at δC 49.0 (C-1), 38.4 (C-6), 41.8 (C-9), and 18.8 (C-20) in 2 were replaced by resonances at δC 45.6, 35.2, 33.0, and 27.2 in 3, respectively, indicating a cis fusion of the decalin ring [6,8,15]. The relative configuration at C-11, however, could not be conclusively determined due to the free rotation around the C-7–C-11 bond.

Cavernene D (4) displayed a HRESIMS [M + Na]+ peak at m/z 354.2407 corresponding to a molecular formula of C21H33O2N, implying six degrees of unsaturation. Many similarities of the 1H and 13C NMR data between 2 and 4 (Table 1 and Table 2) suggested they were structural analogs, with the main differences due to the presence of a trisubstituted epoxide (δC 62.33 and 62.27) in 4 and the absence of two saturated carbons (δC 30.8 and 35.65) in 2. The C-11/C-12 position of the epoxy group was determined by a COSY correlation of H-12/H-13 and HMBC correlations of H3-18/C-7, C-11, and C-12 and H-13/C-11 and C-12. The relative configuration of the decalin ring of 4, found to agree with 2, was established by observation of NOESY correlations of NH/H-1, H-1/H-7, and H3-20/H-6. The relative configurations of C-7 and C-11 between the conjoined bicyclic ring systems in 4 were assigned as 7S* and 11 S*, respectively, based on NOESY correlations of H3-18/H-6, H3-18/H-8b, and H-8a/H-13, as shown in the Newman projection (Figure 3). Thus, the epoxy group was determined as in β-orientation.

Key NOESY correlations of 4.

Kalihinene E (5) was isolated as colorless needles (MeOH), and given a C21H34NO2Cl molecular formula with five degrees of unsaturation, based on the HRESIMS (m/z 368.2354 [M + H]+) and NMR spectra. The ESIMS of 5 showed a cluster of isotopic [M + H]+ ion peaks at m/z 368/370 in a ratio of ~3:1, indicating the presence of a chlorine atom in the molecule. The NMR spectra of 5 revealed the presence of five methyls [δH 1.22 (6H, s), 1.31 (3H, s), 1.39 (3H, s), and 1.65 (3H, s)], an olefinic methine [δH 6.37 (1H, br s), δC 125.7 (CH), and δC 132.4 (qC)], a chlorine-bearing methine [δH 3.93 (1H, m)/δC 64.2], and two oxygenated quaternary carbons (δC 74.2 and 76.9) for the major s-trans isomer (Table 1 and Table 2). Analysis of the 2D NMR (HSQC, HMBC, and COSY) data (Figure 4) revealed that 5 possessed the same carbon skeleton as kalihinene X (11) and Y (12) [15].

COSY (▬), key HMBC (→), and key NOESY correlations of 5.

The relative configuration of the decalin ring in 5 was the same as 12, inferred from the chemical shifts of C-1 to C-10 and NOESY correlations of H-1/H-7, H3-20/H-6, and NH/H-1. A significant difference between 5 and 12 was found in the chemical shift of C-12 (δC 31.0 in 5 instead of δC 38.2 in 12), which was caused by the γ-gauche effect [20,21,22,23,24], indicating an axial orientation of Cl–14. The relative configurations of C-7 and C-11 in 5 were determined as S* and R*, respectively, from NOESY correlations of H3-18/H-6, H3-18/H-8b, and H-8a/H-12, as shown in the Newman projection (Figure 4). Finally, the absolute configuration of 5 was unambiguously determined as 1S, 6S, 7S, 10S, 11R, and 14R by single crystal X-ray diffraction using Cu Kα radiation (Figure 5).

ORTEP drawing of compound 5.

Kalihinene F (6) was isolated as a colorless oil and given a C21H33NO2 molecular formula based on HRESIMS measurements (m/z 354.2406 [M + Na]+) in combination with extensive NMR analysis. The NMR spectra of 6 (Table 1 and Table 2) revealed the presence of five methyls [δH 1.18 (3H, s), 1.20 (3H, s), 1.31 (3H, s), and 1.68 (6H, s)], two trisubstituted double bonds [δH 5.70 (br s), δC 127.1 (CH), and δC 131.1 (qC); δH 5.32 (br s), δC 120.2 (CH), and δC 136.9 (qC)], an oxymethine [δH 3.75 (t, J = 7.0 Hz)/δC 84.2], and an oxygenated quaternary carbons (δC 86.4) for the major s-trans isomer. The COSY correlations of H3-20/H-9/H-8/H-7/H-6/H-1/H-2/H-3 and H-6/H-5/H3-19, together with the HMBC correlations of H3-19/C-3, C-4, and C-5, H3-20/C-1, C-10, and C-9, H-5/C-1, C-3, and C-6, H-2 and H-3/C-4, and H-8/C-10 indicated the presence of a decalin moiety (Figure 6). A tetrahydrofuran ring, attached to the decalin ring at C-7, was established by carbon resonances at δC 84.2 (C-14) and 86.4 (C-11), COSY correlations of H-12/H-13/H-14, HMBC correlations of H3-18/C-7, C-11, and C-12 and geminal methyls (H3-16 and H3-17)/C-14 and C-15, and NOESY correlation between H3-18 and H-14. The location of the formamide functionality was assigned to be at C-15 by the observation of doubled singlets for H3-16 [δH 1.31 (s) and 1.38 (s) for s-trans and s-cis isomers, respectively] and H3-17 [δH 1.20 (s) and 1.34 (s) for s-trans and s-cis isomers, respectively] and doubled triplets for H-14 [δH 3.75 (t, 7.0) and 3.80 (t, 7.0) for s-trans and s-cis isomers, respectively] [6]. The relative configuration of 6 was determined by NOESY correlation of H-1/H-6 and carbon resonances at δC 40.1 (C-1), 36.5 (C-6), and 44.9 (C-7) [6]. NOESY correlations of H3-18/H-6, H3-18/H-8b, and H-8/H-12b defined the relative configurations of 7S*, 11R*, as shown in the Newman projection (Figure 6).

COSY (▬), key HMBC (→), and key NOESY () correlations of 6.

Kalihypyran C (7), a colorless oil, had a molecular formula of C21H31NO2 established by HRESIMS at m/z 352.2255 [M + Na]+, indicating seven degrees of unsaturation. Its 1H and 13C NMR spectra (Table 1 and Table 2) showed the presence of three methyls [δH 1.55 (3H, s), 1.62 (3H, s), 1.78 (3H, s)], two trisubstituted double bonds [δH 5.39 (br s), δC 123.9 (CH), and δC 134.5 (qC); δH 5.61 (br s), δC 118.6 (CH), and δC 139.0 (qC)], a disubstituted double bond [δH 4.88 (br s), 5.01 (br s), δC 110.5 (CH2), and δC 145.4 (qC)], an oxymethylene [δH 4.16 (s, 2H)/δC 67.63], and an oxymethine δH [3.89 (br s)/δC 77.2] for s-cis isomer. Many similarities of the 1H and 13C NMR data between 7 and 8 suggested they were structural analogs [16], the COSY correlations of H3-19/H-5/H-6, H3-17/H-16, and H-18/H-12/H-13/H-14 and the HMBC correlations of H3-19/C-3, C-4, and C-5, H3-20/C-1, C-9, and C-10, H3-17/C-14, C-15, and C-16, and H2-16/C-14, C-15, and C-17 further confirmed 7 possessed the same carbon skeleton as 8. The chemical shifts of C-1, C-6, and C-20 for s-trans isomers in 7 (δC 45.4, 36.6, and 29.7, respectively) were different from those in 8 (δC 48.9, 39.4, and 18.9, respectively), indicated cis fusion of the decalin ring in 7 [16]. The NOESY correlations of H-1/H-6, H-1/H3-20, and H-6/H3-20 confirmed the relative configurations as 7. However, the relative configuration of H-14 was not determined.

The isolated compounds were assessed for their cytotoxicity against a small panel of human cancer cell lines (human colon cancer cell line HCT-116, human lung epithelial cell line A549, human cervical carcinoma cell line HeLa, human hepatocellular carcinoma cell line QGY-7701, and human mammary cancer cell line MDA-MB-231) using a MTT method, and camptothecin (Shanghai Dibai Chemical Co., Shanghai, China; purity ≥98%) was used as positive control. Compounds 1 and 2 showed moderate cytotoxic activities against HCT-116 with IC50 values of 6.31 and 8.99 μM, respectively. Compounds 5 showed cytotoxic activity against HCT-116, HeLa, QGY-7701 and MDA-MB-231 with IC50 values of 14.36, 13.36, 17.78 and 12.84 μM, respectively (Table 3). In addition, compounds 1–12 were tested for antifungal activity against fungi Candida albicans, Candida parapsilosis, Candida glabrata, Cryptococcus neoformans, Trichophyton rubrum, Microsporum gypseum, and Aspergillus fumigatus. Compound 9 showed weak antifungal activity against T. rubrum and M. gypseum with MIC values of 8 and 32 μg/mL, respectively. Compound 10 displayed weak antifungal activity against fungi C. albicans, C. neoformans, T. rubrum, and M. gypseum with MIC values of 8, 8, 4, and 8 μg/mL, respectively. Ketoconazole (Shanghai Aiyan Chemical Co., Shanghai, China; purity ≥98%) was used as positive control with MIC value ≤0.25 μg/mL. It is worth noting that the isonitrile functionalities in the diterpenes play an important role in their antifungal activity.

marinedrugs-10-01445-t003_Table 3

Cytotoxicities of compounds 1–12 in five cancer cell lines.

Cytotoxicity IC50 (μM)
HCT-116 A549 HeLa QGY-7701 MDA-MB-231
1 6.31 >50 >50 >50 >50
2 8.99 >50 >50 >50 >50
3 >50 >50 >50 >50 >50
4 >50 >50 >50 >50 >50
5 14.36 >50 13.36 17.78 12.84
6 >50 >50 >50 >50 >50
7 >50 >50 >50 >50 >50
8 >50 13.09 11.19 13.53 >50
9 >50 17.53 14.74 16.39 >50
10 >50 6.98 13.30 14.53 6.84
11 12.25 8.55 10.59 13.02 7.46
12 >50 17.12 10.05 14.41 15.23
camptothecin 9.25 2.32 6.98 4.05 0.50
3. Experimental Section 3.1. General Experimental Procedures

Optical rotation data were determined with a Perkin-Elmer 341 polarimeter (Perkin-Elmer, Inc., Waltham, MA, USA) with a 1 dm cell. UV spectra were collected using a Shimadzu UV 240 spectrophotometer (Shimadzu Corp., Kyoto, Japan). IR spectra were recorded on a Bruker vector 22 spectrometer (Bruker Optics, Inc., Billerica, MA, USA) with KBr pellets. NMR experiments were conducted on Bruker Avance-500 and AMX-400 spectrometers (Bruker Biospin Corp., Billerica, MA, USA). The HRESIMS spectra were acquired with a Waters Q-Tof micro YA019 mass spectrometer (Waters Corp., Milford, MA, USA). X-ray structure analysis was performed on a Bruker SMART APEX-II CCD diffractometer (Bruker Optics, Inc.). Melting points were obtained on an SGW X-4 melting point apparatus (Shanghai Precision & Scientific Instrument Co., Ltd, Shanghai, China). Reversed-phase HPLC was carried out on a YMC-Pack ODS-A column (250 × 10 mm, 5 µm; YMC Co., Ltd., Kyoto, Japan) using a Waters 1525 HPLC instrument with Waters 2998 UV detector and monitored at 210 nm. Silica gel (200–300 mesh, Qingdao Chengyang Ocean Chemical Co., Jinan, China), Sephadex LH-20 (Pharmacia Fine Chemicals, Piscataway, NJ, USA), and YMC ODS-A (50 μm, YMC Co., Ltd, Kyoto, Japan) were used as column packing materials. Fractions were monitored by TLC (HSGF 254, Yantai Huiyou Co., Yantai, China), and spots were visualized by heating silica gel plates sprayed with 12% H2SO4 in EtOH.

 3.2. Animal Material

Samples of A. cavernosa were collected by hand using scuba around Xisha Islets in the South China Sea in March 2009 and identified by Professor Jin-He Li (Institute of Oceanology, Chinese Academy of Sciences, China). A voucher sample (JHQ-0901) was deposited in the Laboratory of Marine Drugs, Department of Pharmacy, Changzheng Hospital, Second Military Medical University, China.

 3.3. Extraction and Isolation

The sponge (5.5 kg, wet weight) was extracted with acetone at room temperature five times (5 × 5 L) and the extract was concentrated to a brown oil, which was redissolved in H2O (2 L). The aqueous solution was extracted with CH2Cl2 (4 × 2 L) to afford a CH2Cl2-soluble extract (89 g). The resulting extract was partitioned between petroleum ether (4 × 1 L) and 90% aqueous MeOH (4 × 1 L) to yield a brownish red oil (49 g), which was subjected to column chromatography (80 × 7.0 cm) on silica gel (1000.5 g) eluting with petroleum ether-acetone gradient (stepwise, 0:1, 50:1, 30:1, 15:1, 8:1, 3:1 to 0:1, 40 L), and finally MeOH, to give eight fractions (Fractions 1–8). Fraction 5 (5.4 g) was fractionated over Sephadex LH-20 (40 × 2000 mm, eluted with CH2Cl2/MeOH 1:1, 1.5 L), and further fractionated by CC on ODS (RP-18, 30 × 500 mm), eluted with 70%–100% MeOH/H2O, to give four subfractions (Fractions 5a–d). Fraction 5a (203.4 mg) was purified by HPLC (YMC-Pack ODS-A, 5 µm, 10 × 250 mm, 2.0 mL/min, UV detection at 210 nm), using MeOH/H2O (88:12) as eluent, to yield 7 (2.1 mg, tR = 40.5 min) and 8 (4.2 mg, tR = 42.5 min). Fraction 5b (659 mg) was subjected to CC (15 × 300 mm) on silica gel (15 g), using CH2Cl2/MeOH with increasing polarity (1:0, 100:1, 50:1) as mobile phase, to yield compound 4 (13.3 mg). Fraction 5c (368.0 mg) was purified by HPLC (YMC-Pack ODS-A, 5 µm, 10 × 250 mm, 2.0 mL/min, UV detection at 210 nm), using MeOH/H2O (92:8) as eluent, to afford 1 (48.9 mg, tR = 36.6 min), 3 (4.2 mg, tR = 40.8 min), and 2 (50.7 mg, tR = 43.8 min). Fraction 5d (267.5 mg) was chromatographied (15 × 300 mm) on silica gel (15 g, eluted with CH2Cl2/MeOH 50:1), to obtain 10 (160 mg). Fraction 6 (7.4 g) was applied to Sephadex LH-20 (40 × 2000 mm) eluted with CH2Cl2/MeOH (1:1) to furnish three subfractions (Fractions 6a and c). Fraction 6b (1.3 g) was subjected to CC on ODS (RP-18, 30 × 500 mm), eluting with 80%–100% MeOH, to give five subfractions (Fractions 6b1–5). Fraction 6b2 (123 mg) was purified by HPLC (YMC-Pack ODS-A, 5 µm, 10 × 250 mm, 2.0 mL/min, UV detection at 210 nm) using MeOH/H2O (92:8) as eluent to 9 (1.0 mg, tR = 37.5 min). Fraction 6b3 (31.5 mg) was fractioned by a Sephadex LH-20 column (15 × 2000 mm) eluting with hexane/CH2Cl2/MeOH (5:4:1) to afford 6 (4.5 mg). Compound 5 (50.9 mg) was obtained from fraction 6b4 (478.5 mg) by a CC (15 × 300 mm) on silica gel (15 g, eluted with CH2Cl2/MeOH 30:1). Fraction 7 (8.3 g) was subjected to CC (40 × 2000 mm) on Sephadex LH-20 eluting with MeOH followed by HPLC purification (YMC-Pack ODS-A, 5 µm, 10 × 250 mm, 2.0 mL/min, UV detection at 210 nm) using MeOH/H2O (90:10) as eluent to yield 11 (201.5 mg, tR = 50.4 min) and 12 (197.6 mg, tR = 56.8 min).

Cavernene A (1): colorless oil; [α] +25.0 (c 0.06, MeOH); UV (CH3CN) λmax (log ε) < 200 (2.45) nm; IR (KBr) νmax 3323, 3051, 2927, 2856, 1670, 1541, 1457, 1386 cm−1; 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 338.2461 [M + Na]+ (calcd for C21H33NONa, 338.2460).

Cavernene B (2): colorless oil; [α] +46.2 (c 0.07, MeOH); UV (CH3CN) λmax (log ε) < 200 (2.79), 234 (sh, 2.25) nm; IR (KBr) νmax 3295, 3053, 2960, 2926, 2869, 1681, 1537, 1453, 1382 cm−1; 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 340.2617 [M + Na]+ (calcd for C21H35NONa, 340.2616).

Cavernene C (3): white needles (MeOH); m.p. 98.0–102.0 °C; [α] +20.0 (c 0.03, MeOH); UV (CH3CN) λmax (log ε) < 200 (2.95) nm; IR (KBr) νmax 3304, 3062, 2958, 2926, 2855, 1668, 1538, 1455, 1381 cm−1; 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 340.2614 [M + Na]+ (calcd for C21H35NONa, 340.2616).

Cavernene D (4): colorless needles (MeOH); m.p. 112.0–115.0 °C; [α] +51.4 (c 0.04, MeOH); UV (CH3CN) λmax (log ε) < 200 (2.88) nm; IR (KBr) νmax 3296, 3055, 2928, 2857, 1681, 1538, 1453, 1383 cm−1; 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 354.2407 [M + Na]+ (calcd for C21H33NO2Na, 354.2409).

Kalihinene E (5): colorless needles (MeOH); m.p. 185.0–190.0 °C; [α] +25.0 (c 0.04, MeOH); UV (CH3CN) λmax (log ε) < 200 (2.94) nm; IR (KBr) νmax 3295, 3074, 2929, 2868, 1682, 1541, 1451, 1381 cm−1; 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 368.2354 [M + H]+ (calcd for C21H35NO2Cl, 368.2356).

Kalihinene F (6): colorless oil; [α] +2.5 (c 0.08, MeOH); UV (CH3CN) λmax (log ε) < 200 (2.63), 232 (sh, 2.12) nm; IR (KBr) νmax 3216, 3057, 2966, 2929, 1686, 1451, 1379, 1311 cm−1; 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 354.2406 [M + Na]+ (calcd for C21H33NO2Na, 354.2409).

Kalihipyran C (7): colorless oil; [α] +24.6 (c 0.07, MeOH); UV (CH3CN) λmax (log ε) < 200 (2.87) nm; IR (KBr) νmax 3296, 3055, 2925, 2855, 1668, 1537, 1454, 1377 cm−1; 1H and 13C NMR data, see Table 1 and Table 2; HRESIMS m/z 352.2255 [M + Na]+ (calcd for C21H31NO2Na, 352.2252).

X-ray Crystallographic Analysis Data of Kalihinene E (5): Colorless needles, C21H34NO2Cl, MW = 367.94, monoclinic space group P21, a = 6.499 (2) Å, b = 7.952 (2) Å, c = 20.158 (4) Å, V = 1036.1 (4) Å3, Z = 2, Dcalcd = 1.179 g/cm3, and F (000) = 400. A single crystal of dimensions 0.05 × 0.13 × 0.18 mm was used for X-ray measurements and data collected on a Bruker SMART APEX-II CCD diffractometer using Cu Kα radiation and up to θ = 67.3 at 293 K. A total of 5789 reflections were collected, of which 3435 independent reflections were measured having an Rint of 0.0220, final R indices of I > 2σ (I), R1=0.0426, wR2 = 0.1163, R indices for all data R1 = 0.0445, and wR2 = 0.1184. The crystal structure solution was achieved using direct methods, as implemented with the SHELX-97 software program. The refinment method was full-matrix least-square on F2, goodness-of-fit on F2 was 1.042, and the largest difference peak and hole were 0.237 and −0.196 e. Å-3. The absolute structure was determined giving a Flack parameter of 0.07 (2). The X-ray diffraction material has been deposited in the Cambridge Crystallographic Data Center (CCCD No. 847695).

 3.4. Cytotoxicity Assay

Cytotoxic activity was evaluated by a MTT method as described previously [25]. Cells were cultured in RPMI-1640 supplemented with 10% fetal bovine serum in 5% CO2 at 37 °C. An aliquot (200 μL) of these cell suspensions at a density of 5 × 10−4 cell mL−1 was plated in 96-well microtiter plates and incubated for 24 h under the above conditions. 2 μL of the test compound in DMSO at different concentrations was added to each well for 48 h, and then incubated with 1 mg/mL MTT for 4 h. The formazan dye product was measured by the absorbance at 570 nm on a microplate reader. IC50 values were calculated by Reed and Muench’s method.

 3.5. Antifungal Activity Assay

Antifungal activity was determined by the broth macrodilution method following the National Center for Clinical Laboratory Standards (NCCLS) recommendations against the following strains: Candida albicans, Candida parapsilosis, Candida glabrata, Cryptococcus neoformans, Trichophyton rubrum, Microsporum gypseum, and Aspergillus fumigates [26,27]. Briefly, bacterial strains were grown aerobically at 30 °C in SDA for 16–20 h in an orbital shaker. A set of tube swith different concentrations of compounds 1–12 prepared in RPMI 1640 were next inoculated with the microorganisms and incubated 24 h for C. albicans, C. parapsilosis, C. glabrata, and A. fumigatus, 72 h for C. neoformans, and 4–7 days for T. rubrum and M. gypseum. Broth tubes that appeared turbid were indicative of bacterial growth, while tubes that remained clear indicated no growth. The MIC, defined as the lowest concentration of inhibitory compound at which no growth was observed, was evaluated in triplicate for each compound (within the range 1.25–640 μg/mL). Cultures prepared under the same conditions but without compounds and cultures with the same proportions of DMSO (<1%) were used as controls. The growth of broth tubes without turbidity was further examined by counting the viable cells on the SDA plates.

 4. Conclusions

A chemical investigation of the marine sponge of Acanthella cavernosa led to the isolation of seven new fomamido-diterpenes, cavernenes A–D (1–4), kalihinenes E and F (5,6), and kalihipyran C (7), and five known compounds, kalihipyran A (8), 15-formamido-kalihinene (9), 10-formamido-kalihinene (10), and kalihinenes X (11) and Y (12). The absolute configuration of 5 was determined by single X-ray diffraction. The isolated compounds showed modest cytotoxicity against a small panel of human cancer cell lines, HCT-116, A549, HeLa, QGY-7701 and MDA-MB-231. Compounds 9 and 10 displayed antifungal activity against Trichophyton rubrum and Microsporum gypseum, Candida albicans, and Cryptococcus neoformans.

 Acknowledgments

We would like to thank Jin-He Li of the Institute of Oceanology, Chinese Academy of Sciences for his help in identifying the marine sponges. This work was funded by the National Natural Science Foundation of China (Nos. 81072573, 81172978, 41106127, and 81001394), the National Science & Technology Major Project of China (No. 2009ZX09103-427), and the Major Program of Modernization of Chinese Medicine (STCSM, 09dZ1975800). Financial support from the National High Technology Research and Development Program of China (863 Project, 2011AA09070107) is gratefully acknowledged.

 References Chang C.W.J. Patra A. Baker J.A. Scheuer P.J. Kalihinols, multifunctional ditepenoid anntibiotics from marine sponges Acanthella spp J. Am. Chem. Soc. 1987 109 6119 6123 10.1021/ja00254a035 Trimurtulu G. Faulkner D.J. Six new ditepene isonitriles from the sponge Acanthella cavernosa J. Nat. Prod. 1994 57 501 506 10.1021/np50106a009 Clark R.J. Stapleton B.L. Garson M.J. New isocyano and isothiocyanato terpene metabolites from the topical marine sponge Acanthella cavernosa Tetrahedron 2000 56 3071 3076 10.1016/S0040-4020(00)00226-X Angerhofer C.K. Pezzuto J.M. Antimalarial activity of sesquiterpenes from the marine sponge Acanthella klethra J. Nat. Prod. 1992 55 1787 1789 10.1021/np50090a014 Jumaryatno P. Stapleton B.L. Hooper J.N.A. Brecknell D.J. Blanchfield J.T. Garson M.J. A comparison of sesquiterpene scaffolds across different populations of the tropical marine sponge Acanthella cavernosa J. Nat. Prod. 2007 70 1725 1730 10.1021/np070156d17953446 Rodriguez J. Nieto R.M. Huter L.M. Diaz M.C. Crews P. Variation among known kalihinol and new kalihinene diterpenes from the sponge Acanthella cavernosa Tetrahedron 1994 50 11079 11090 10.1016/S0040-4020(01)89411-4 Sun J.Z. Chen K.S. Yao L.G. Liu H.L. Guo Y.W. A new kalihinol diterpene from the hainan sponge Acanthella sp Arch. Pharm. Res. 2009 32 1581 1584 10.1007/s12272-009-2110-420091271 Fusetani N. Yasumura E. Kawai H. Natori T. Binnen L. Clardy J. Kalihinene and isokalihinol B, cytotoxic diterpene isonitriles from the marine sponge Acanthella klethra Tetrahedron Lett. 1990 31 3559 3602 10.1016/S0040-4039(00)94442-3 Omar S. Albert C. Fanni T. Crews P. Polyfunctional diterpene isonitriles from marine sponge Acanthella cavernosa J. Org. Chem. 1988 53 5971 5972 10.1021/jo00260a034 Alvi K.A. Tenenbaum L. Crews P. Anthelmintic polyfunctional nitrogen-containing terpenoids from marine sponges J. Nat. Prod. 1991 54 71 78 10.1021/np50073a0022045823 Miyaoka H. Shimomura M. Kimura H. Yamada Y. Antimalarial activity of kalihinol A and new relative diterpenoids from the Okinawan sponge, Acanthella sp Tetrahedron 1998 54 13467 13474 10.1016/S0040-4020(98)00818-7 Bugni T.S. Singh M.P. Chen L. Arias D.A. Harper M.K. Greenstein M. Maiese W.M. Concepcion G.P. Mangalindan G.C. Ireland C.M. Kalihinols from two Acanthella cavernosa sponges: Inhibitors of bacterial folate biosynthesis Tetrahedron 2004 60 6981 6988 10.1016/j.tet.2003.08.082 Chang C.W.J. Patra A. Roll D.M. Scheuer P.J. Kalihinol-A, a highly functionalized diisocyano diterpenoid antibiotic from a sponge J. Am. Chem. Soc. 1984 106 4644 4646 10.1021/ja00328a073 Patra A. Chang C.W.J. Scheuer P.A. Van Dayne D.G. Matsumoto G.K. Clardy J. An unprecedented triisocyano diterpenoid antibiotic from a sponge J. Am. Chem. Soc. 1984 106 7981 7983 10.1021/ja00337a061 Okino T. Yoshimura E. Hirota H. Fusetani N. Antifouling kalihinenes from the marine sponge Acanthella cavernosa Tedrahedron Lett. 1995 36 8637 8640 10.1016/0040-4039(95)01861-B Okino T. Yoshimura E. Hirota H. Fusetani N. New antifouling kalihipyrans from the marine sponge Acanthella cavernosa J. Nat. Prod. 1996 59 1081 1083 10.1021/np960496r Hirota H. Tomono Y. Fusetani N. Terpenoids with antifouing activity against Barnacle larvae from the marine sponge Acanthella cavernosa Tetrahedron 1996 52 2359 2368 10.1016/0040-4020(95)01079-3 Xu Y. Li N. Jiao W.H. Wang R.P. Peng Y. Qi S.H. Song S.J. Chen W.S. Lin H.W. Antifouling and cytotoxic constituents from the South China Sea sponge Acanthella cavernosa Tetrahedron 2012 6 2876 2883 Garson M.J. Simpson J.S. Marine isocyanides and related natural products—Structure, biosynthesis and ecology Nat. Prod. Rep. 2004 21 164 179 10.1039/b302359c15039841 Dorman D.E. Roberts J.D. Nuclear magnetic resonance spectroscopy. Carbon-13 spectra of some pentose and hexose aldopyranoses J. Am. Chem. Soc. 1970 92 1355 1361 10.1021/ja00708a041 Dalling D.K. Grant D.M. Carbon-13 magnetic resonance. IX. The methylcyclohexanes J. Am. Chem. Soc. 1967 89 6612 6622 10.1021/ja01001a039 Ribeiro D.S. Olivato P.R. Rittner R. Axial/equatorial populations in α-hetero-substituted cyclohexanone Oximes and O-methyl oximes Magn. Reson. Chem. 2000 38 627 638 10.1002/1097-458X(200008)38:8<627::AID-MRC680>3.0.CO;2-M Gultekin D.D. Tasxkesenligil Y. Dastan A. Balci M. Bromination of norbornene derivatives: Synthesis of brominated norbornanes and norbornenes Tetrahedron 2008 64 4377 4383 10.1016/j.tet.2008.02.067 Tonelli A.E. Schilling F.C. 13C NMR chemical shifts and the microstructure of propylene-vinyl chloride copolymers with low propylene content Macromolecules 1984 17 1946 1949 10.1021/ma00140a011 Zhang H.J. Yi Y.H. Yang G.J. Hu M.Y. Cao G.D. Yang F. Lin H.W. Proline-containing cyclopeptides from the marine sponge Phakellia fusca J. Nat. Prod. 2010 73 650 655 10.1021/np9008267 Clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi: Approved Standard; NCCLS M38-A2 Clinical Laboratory Standards Institute Wayne, PA, USA 2008 Clinical and Laboratory Standards Institute Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard; NCCLS M27-A3 Clinical and Laboratory Standards Institute Wayne, PA, USA 2009

Samples Availability: Available from the authors.

 Supplementary Files

PDF-Document (PDF, 9743 KB)